Dishman Carbogen Amcis informs about credit rating

22 Dec 2022 Evaluate
Dishman Carbogen Amcis has informed that India Ratings & Research ('Ind-Ra') has affirmed the Company's Rating for long term credit facilities at 'IND A+', for short term credit facilities at 'IND A1+', and assigned Rating for Proposed non-convertible debentures/term loan at 'IND A+’ with a 'Stable' outlook. Since the company did not proceed with the commercial paper instrument as envisaged, based upon company's request, it has withdrawn Rating for this instrument. Details of instrument wise rating are mentioned in the attached file.

The above information is a part of company’s filings submitted to BSE.

Dishman Carbogen Amc Share Price

223.15 -5.45 (-2.38%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×